This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Fresenius Medical Care AG & Co. KGaA (FMS)

NYSE: Health Care

Company Cash Flow
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash Flow From Operating Activities
Net Income (Loss) 1.26B 1.26B 1.33B 1.18B
Operating Gains/Losses 25.78M -30.65M -146.61M -8.98M
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -276.21M -52.25M -69.20M -264.46M
(Increase) Decrease in Inventories -85.76M -54.92M -48.28M -151.89M
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables 235.25M 211.52M 10.06M 127.91M
(Decrease) Increase In Other Current Liabilities -94.92M -36.06M -38.48M 41.04M
(Increase) Decrease In Other Working Capital 0.00 0.00 225.59M 0.00
Other Non-Cash Items 8.51M 9.52M 12.53M 118.41M
Net Cash From Continuing Operations 1.86B 2.03B 2.04B 1.45B
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 1.86B 2.03B 2.04B 1.45B
Sale of Property, Plant & Equipment 11.67M 19.85M 9.67M 27.32M
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -931.63M -747.94M -675.31M -597.86M
Acquisitions -1.77B -477.45M -1.62B -1.78B
Purchases of Short-Term Investments 0.00 0.00 0.00 0.00
Other Cash from Investing Activities 0.00 0.00 0.00 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities -2.69B -1.21B -2.28B -2.35B
Issuance of Debt 3.41B 841.47M 4.96B 3.04B
Cash Used for Financing Activities
Issuance of Capital Stock 107.05M 111.30M 121.13M 94.89M
Repayment of Long-Term Debt -2.18B -1.03B -3.82B -1.33B
Repurchase of Capital Stock 0.00 -505.01M 0.00 -653.76M
Payment of Cash Dividends -568.17M -296.13M -466.76M -410.19M
Other Financing Charges, Net 32.86M 73.74M -334.80M 52.32M
Net Cash From Financing Activities 805.01M -808.04M 468.34M 793.16M
Effect of Exchange Rate Changes -24.57M -26.49M 4.59M 40.65M
Net Change in Cash & Cash Equivalents -48.92M -5.26M 230.75M -65.58M
FMS News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

FMS Fresenius Medical Care AG & Co. KGaA

Chart of FMS

Analysts Ratings for FMS

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 7 7 7 7
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0

FMS Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs